Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6703)
All Articles published online
|
Publishing Process of This Article
|
Dec 14, 2020 (publication date) through Nov 22, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Hoffmann P, Jung V, Behnisch R, Gauss A. Prevalence and risk factors of nonalcoholic fatty liver disease in patients with inflammatory bowel diseases: A cross-sectional and longitudinal analysis. World J Gastroenterol 2020; 26(46): 7367-7381 [PMID: 33362390 DOI: 10.3748/wjg.v26.i46.7367] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v26/i46/7367.htm |
| Number | Citing Articles |
| 1 |
Apostolis Papaefthymiou, Spyros Potamianos, Antonis Goulas, Michael Doulberis, Jannis Kountouras, Stergios A Polyzos. Inflammatory Bowel Disease-associated Fatty Liver Disease: the Potential Effect of Biologic Agents. Journal of Crohn's and Colitis 2022; 16(5): 852 doi: 10.1093/ecco-jcc/jjab212
|
| 2 |
Athri Kodali, Chiugo Okoye, Dhadon Klein, Iman Mohamoud, Olawale O Olanisa, Panah Parab, Priti Chaudhary, Sonia Mukhtar, Ali Moradi, Pousette Hamid. Crohn’s Disease is a Greater Risk Factor for Nonalcoholic Fatty Liver Disease Compared to Ulcerative Colitis: A Systematic Review. Cureus 2023; doi: 10.7759/cureus.42995
|
| 3 |
Lívia dos Remédios Pamplona de Oliveira, Tarsila Campanha da Rocha Ribeiro, Carlos Alberto Mourao Junior, Maria Antônia de Lima Barra, Mariana Hippert Gonçalves Silva, Luis Pordeus Shafee, Sarah Mendes Zacarias, Lenilton da Costa Campos, Helena Maria Giordano Valério, Júlio Maria Fonseca Chebli. Metabolic dysfunction-associated steatotic liver disease prevalence and risk factors in inflammatory bowel disease in tertiary center. Revista da Associação Médica Brasileira 2024; 70(6) doi: 10.1590/1806-9282.20231321
|
| 4 |
Paulina Núñez F, Fabiola Castro, Gabriel Mezzano, Rodrigo Quera, Diego Diaz, Lorena Castro. Hepatobiliary manifestations in inflammatory bowel disease: A practical approach. World Journal of Hepatology 2022; 14(2): 319-337 doi: 10.4254/wjh.v14.i2.319
|
| 5 |
Rossella Maresca, Irene Mignini, Simone Varca, Valentin Calvez, Fabrizio Termite, Giorgio Esposto, Lucrezia Laterza, Franco Scaldaferri, Maria Elena Ainora, Antonio Gasbarrini, Maria Assunta Zocco. Inflammatory Bowel Diseases and Non-Alcoholic Fatty Liver Disease: Piecing a Complex Puzzle Together. International Journal of Molecular Sciences 2024; 25(6): 3278 doi: 10.3390/ijms25063278
|
| 6 |
Ying-Hsiang Wang, Chi-Hsiang Chung, Tien-Yu Huang, Chao-Feng Chang, Chi-Wei Yang, Wu-Chien Chien, Yi-Chiao Cheng. Association between nonalcoholic fatty liver disease and incidence of inflammatory bowel disease: a nationwide population‑based cohort study. Intestinal Research 2024; doi: 10.5217/ir.2023.00078
|
| 7 |
Scott McHenry, Matthew Glover, Ali Ahmed, Quazim Alayo, Maria Zulfiqar, Daniel R Ludwig, Matthew A Ciorba, Nicholas O Davidson, Parakkal Deepak. NAFLD Is Associated With Quiescent Rather Than Active Crohn’s Disease. Inflammatory Bowel Diseases 2024; 30(5): 757 doi: 10.1093/ibd/izad129
|
| 8 |
Iván Ferraz-Amaro, Alejandro Hernández-Camba, Marta Carrillo-Palau, Noemi Hernández Álvarez-Buylla, Antonia de Vera-González, Alejandra González-Delgado, Elena Heras-Recuero, Miguel Á. González-Gay. Liver Fibrosis Index-4 Does Not Correlate to Liver Elastography in Patients with Inflammatory Bowel Disease. Journal of Clinical Medicine 2024; 13(21): 6430 doi: 10.3390/jcm13216430
|
| 9 |
Min Xu, Tong Wu, Zhaoxia Li, Guijie Xin. Influence of genetically predicted autoimmune diseases on NAFLD. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1229570
|
| 10 |
Somtochukwu Onwuzo, Antoine Boustany, Mustafa Saleh, Riya Gupta, Chidera Onwuzo, Jessy Mascarenhas Monteiro, Favour Lawrence, Chukwuemeka Obuekwe, Zoya Morani, Imad Asaad. Increased Risk of Non-Alcoholic Steatohepatitis in Patients With Inflammatory Bowel Disease: A Population-Based Study. Cureus 2023; doi: 10.7759/cureus.35854
|
| 11 |
Rui Gaspar, Catarina Castelo Branco, Guilherme Macedo. Liver manifestations and complications in inflammatory bowel disease: A review. World Journal of Hepatology 2021; 13(12): 1956-1967 doi: 10.4254/wjh.v13.i12.1956
|
| 12 |
Ya Yuan, Dazuo Wu, Heping Chen, Zheng Ma, Xinyue Peng, Xiaodie Li, Chuchu Zhao, Linping Jiang, Jinping Liang, Weiwei Zhang, Juan Dai. Farnesol ameliorates DSS-induced IBD by regulating inflammatory cytokines, repairing the intestinal barrier, reversing the gut microbiota imbalance, and influencing fecal metabolome in C57BL/6 mice. Biomedicine & Pharmacotherapy 2024; 180: 117518 doi: 10.1016/j.biopha.2024.117518
|
| 13 |
Ludovico Abenavoli, Lidia Giubilei, Anna Caterina Procopio, Rocco Spagnuolo, Francesco Luzza, Luigi Boccuto, Emidio Scarpellini. Gut Microbiota in Non-Alcoholic Fatty Liver Disease Patients with Inflammatory Bowel Diseases: A Complex Interplay. Nutrients 2022; 14(24): 5323 doi: 10.3390/nu14245323
|
| 14 |
Alireza Beheshti Maal, Mohammad Amin Shahrbaf, Bahareh Sadri, Nikoo Hossein-Khannazer, Mohammad Ali Mansournia, Massoud Vosough. Prevalence of Hepatobiliary Manifestations in Inflammatory Bowel Disease: A GRADE Assessed Systematic Review and Meta-Analysis of more than 1.7 Million Patients. Journal of Crohn's and Colitis 2024; 18(3): 360 doi: 10.1093/ecco-jcc/jjad157
|
| 15 |
Qijin Hong, Jun Shen, Qi Feng, Qing Zheng, Yuqi Qiao. Prevalence and predictors of non-alcoholic liver disease on MRI among patients with Crohn's disease. BMC Gastroenterology 2022; 22(1) doi: 10.1186/s12876-022-02238-5
|
| 16 |
Ludovico Abenavoli, Rocco Spagnuolo, Giuseppe Guido Maria Scarlata, Emidio Scarpellini, Luigi Boccuto, Francesco Luzza. Ultrasound Prevalence and Clinical Features of Nonalcoholic Fatty Liver Disease in Patients with Inflammatory Bowel Diseases: A Real-Life Cross-Sectional Study. Medicina 2023; 59(11): 1935 doi: 10.3390/medicina59111935
|
| 17 |
Stefano Mazza, Sara Soro, Maria Chiara Verga, Biagio Elvo, Francesca Ferretti, Fabrizio Cereatti, Andrea Drago, Roberto Grassia. Liver-side of inflammatory bowel diseases: Hepatobiliary and drug-induced disorders. World Journal of Hepatology 2021; 13(12): 1828-1849 doi: 10.4254/wjh.v13.i12.1828
|
| 18 |
Mohammad Zamani, Shaghayegh Alizadeh‐Tabari, Siddharth Singh, Rohit Loomba. Meta‐analysis: prevalence of, and risk factors for, non‐alcoholic fatty liver disease in patients with inflammatory bowel disease. Alimentary Pharmacology & Therapeutics 2022; 55(8): 894 doi: 10.1111/apt.16879
|
| 19 |
Samuel J. Martínez-Domínguez, Sandra García-Mateo, Carla J. Gargallo-Puyuelo, Beatriz Gallego Llera, Engy Refaie, Pilar Callau, Carolina Mendi, Pedro M. Baptista, María Hernández Ainsa, María Teresa Arroyo-Villarino, Julia López de la Cruz, Javier Martínez-García, Erika Alfambra, Miguel Ángel Simón Marco, Javier Ampuero, Fernando Gomollón. Crohn´s disease is an independent risk factor for liver fibrosis in patients with inflammatory bowel disease and non-alcoholic fatty liver disease. European Journal of Internal Medicine 2024; 120: 99 doi: 10.1016/j.ejim.2023.10.019
|
| 20 |
Sara Jarmakiewicz-Czaja, Aneta Sokal, Piotr Pardak, Rafał Filip, Alessandro Granito. Glucocorticosteroids and the Risk of NAFLD in Inflammatory Bowel Disease. Canadian Journal of Gastroenterology and Hepatology 2022; 2022: 1 doi: 10.1155/2022/4344905
|
| 21 |
Giovanni Tarantino, Vincenzo Citro. Crosstalk Between the Spleen and Other Organs/Systems: Downstream Signaling Events. Immuno 2024; 4(4): 479 doi: 10.3390/immuno4040030
|
| 22 |
Anca Trifan, Remus Stafie, Adrian Rotaru, Ermina Stratina, Sebastian Zenovia, Robert Nastasa, Laura Huiban, Tudor Cuciureanu, Cristina Muzica, Stefan Chiriac, Irina Girleanu, Ana-Maria Singeap, Catalin Sfarti, Camelia Cojocariu, Oana Petrea, Carol Stanciu. Screening for Liver Steatosis and Fibrosis in Patients with Inflammatory Bowel Disease Using Vibration Controlled Transient Elastography with Controlled Attenuation Parameter. Journal of Clinical Medicine 2022; 11(19): 5959 doi: 10.3390/jcm11195959
|
| 23 |
Hirsh D. Trivedi, Emily W. Lopes, Jeremy Glissen Brown, Shaan Dudani, Michelle Lai, Joseph D. Feuerstein, Theodore T. Pierce. Steroid Use and Risk of Nonalcoholic Fatty Liver Disease in Patients With Inflammatory Bowel Disease. Journal of Clinical Gastroenterology 2023; 57(6): 610 doi: 10.1097/MCG.0000000000001727
|
| 24 |
Pilar Navarro, Lucía Gutiérrez-Ramírez, Antonio Tejera-Muñoz, Ángel Arias, Alfredo J. Lucendo. Systematic Review and Meta-Analysis: Prevalence of Non-Alcoholic Fatty Liver Disease and Liver Fibrosis in Patients with Inflammatory Bowel Disease. Nutrients 2023; 15(21): 4507 doi: 10.3390/nu15214507
|
| 25 |
Apostolis Papaefthymiou, Styliani Sarrou, Konstantinos Pateras, Ilias D. Vachliotis, Georgios Agrotis, Ioanna-Konstantina Sgantzou, Georgios Perifanos, Andreas Kapsoritakis, Matthaios Speletas, Marianna Vlychou, George N. Dalekos, Spyros Potamianos, Antonis Goulas, Jannis Kountouras, Stergios A. Polyzos. The Effect of Biologic Agents on Steatotic Liver Disease in Patients with Inflammatory Bowel Disease: A Prospective, Open-Label Comparative Trial. Pharmaceuticals 2024; 17(11): 1432 doi: 10.3390/ph17111432
|
| 26 |
Lanlan Chen, Zhongqi Fan, Xiaodong Sun, Wei Qiu, Yuguo Chen, Jianpeng Zhou, Guoyue Lv. Mendelian Randomization Rules Out Causation Between Inflammatory Bowel Disease and Non-Alcoholic Fatty Liver Disease. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.891410
|
| 27 |
Joseph-Kevin Igwe, Phani Keerthi Surapaneni, Erin Cruz, Cedric Cole, Kingsley Njoku, Jisoo Kim, Ugo Alaribe, Kelechi Weze, Bilal Mohammed. Bariatric Surgery and Inflammatory Bowel Disease: National Trends and Outcomes Associated with Procedural Sleeve Gastrectomy vs Historical Bariatric Surgery Among US Hospitalized Patients 2009–2020. Obesity Surgery 2023; 33(11): 3472 doi: 10.1007/s11695-023-06833-7
|